Dr. Jenq also has a secondary appointment in Stem Cell Transplantation and Cellular Therapy and is Director of the Microbiome Core Facility. He received his medical training at Oregon Health and Science University, Duke, and Memorial Sloan Kettering Cancer Center. A practicing medical oncologist, his research efforts have focused on studying the effects of the intestinal bacterial flora on outcomes following immune therapy for cancer, including hematopoietic cell transplantation and checkpoint blockade.
An increasing amount of evidence supports the connection between microbes and human diseases. In this session we investigate the association of microbial cell-free DNA to cancer and stem cell transplantation, and explore the unique opportunities for novel medical applications.